Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FN1D0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,110
Award facts
- Contract value 100% obligated
- $10,109.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 28, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, procures 30 tablets of Ondansetron ODT 4 mg, an antiemetic medication commonly used in military and federal healthcare settings. The contract is valued at $10,109.68 with a firm fixed-price structure and no set-aside designation, indicating full and open competition. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with Defense Logistics Agency Troop Support Medical, a $999.99 billion vehicle that runs through December 2031 and serves as the comprehensive pharmaceutical supply mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains the operational capability to fulfill such deliveries as a prime contractor under the DLA's pharmaceutical supply framework. The DLA Troop Support Medical contract vehicle encompasses an extensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. This specific award underscores the contractor's role in supplying essential medications to support defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FN1D0?
SPE2DR26FN1D0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FN1D0 worth?
The government has obligated $10,110 on SPE2DR26FN1D0.
Is contract SPE2DR26FN1D0 an order under another contract?
Yes. SPE2DR26FN1D0 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1D0 competed?
The extent of competition for SPE2DR26FN1D0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award